NPI: 1164609962 · SAN FRANCISCO, CA 94110 · General Acute Care Hospital · NPI assigned 01/24/2008
Authorized official ARNOLD, TIMOTHY controls 20+ related entities in our dataset. Read more
| Authorized Official | ARNOLD, TIMOTHY (DEPUTY DIRECTOR, PFS) |
| NPI Enumeration Date | 01/24/2008 |
Other providers sharing the same authorized official: ARNOLD, TIMOTHY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 37,823 | $69K |
| 2019 | 53,664 | $283K |
| 2020 | 9,762 | $1.08M |
| 2021 | 9,986 | $1.99M |
| 2022 | 14,379 | $2.88M |
| 2023 | 21,733 | $3.80M |
| 2024 | 15,872 | $3.01M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 63,768 | 51,116 | $10.21M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1,951 | 1,408 | $989K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,240 | 708 | $399K |
| 90677 | 401 | 401 | $228K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,867 | 1,587 | $191K |
| 91320 | 594 | 594 | $151K | |
| 96415 | 422 | 321 | $87K | |
| 80061 | Lipid panel | 5,221 | 5,195 | $67K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 828 | 824 | $56K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 361 | 197 | $49K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 76 | 60 | $41K |
| 83036 | Hemoglobin; glycosylated (A1C) | 6,376 | 6,347 | $37K |
| 80053 | Comprehensive metabolic panel | 5,099 | 4,857 | $34K |
| 92250 | 451 | 448 | $34K | |
| 90670 | 565 | 554 | $34K | |
| 87536 | 622 | 609 | $33K | |
| 90732 | 115 | 115 | $33K | |
| 71046 | Radiologic examination, chest; 2 views | 991 | 959 | $30K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5,790 | 5,130 | $29K |
| 91322 | 111 | 111 | $28K | |
| 0760 | 298 | 227 | $21K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 295 | 293 | $20K |
| 90750 | 454 | 454 | $19K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5,064 | 4,392 | $16K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 213 | 213 | $15K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 14 | 14 | $15K |
| 90832 | Psychotherapy, 30 minutes with patient | 42 | 37 | $13K |
| 86780 | 472 | 465 | $12K | |
| 0450 | Emergency room services | 365 | 323 | $12K |
| J3490 | Unclassified drugs | 511 | 305 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,119 | 1,055 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | 175 | 149 | $10K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,158 | 2,104 | $9K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,142 | 1,127 | $9K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 85 | 85 | $8K |
| 82043 | 2,341 | 2,311 | $8K | |
| 82570 | 2,545 | 2,508 | $8K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 822 | 820 | $7K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 864 | 826 | $7K |
| 85027 | 2,758 | 2,644 | $7K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 26 | 26 | $6K |
| 0270 | 13 | 12 | $5K | |
| G0008 | Administration of influenza virus vaccine | 143 | 143 | $5K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 696 | 655 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 517 | 456 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | 259 | 245 | $5K |
| 85610 | 2,015 | 1,764 | $5K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 160 | 159 | $4K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 438 | 396 | $4K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 532 | 486 | $3K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 41 | 40 | $3K |
| 96417 | 20 | 14 | $3K | |
| 84460 | 933 | 886 | $3K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 84 | 70 | $3K |
| 92002 | 13 | 13 | $3K | |
| 99173 | 319 | 319 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 277 | 275 | $3K |
| 83970 | 500 | 490 | $3K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 27 | 27 | $3K |
| 87517 | 344 | 339 | $2K | |
| 82728 | 668 | 655 | $2K | |
| 86592 | 888 | 874 | $2K | |
| 82607 | 425 | 421 | $2K | |
| 82105 | 406 | 404 | $2K | |
| 92134 | 198 | 196 | $2K | |
| 80069 | 798 | 756 | $2K | |
| 84466 | 574 | 563 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 471 | 468 | $1K |
| 82248 | 362 | 354 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 287 | 274 | $1K |
| 84153 | 382 | 373 | $1K | |
| 82803 | 695 | 636 | $1K | |
| 82948 | 1,843 | 1,442 | $1K | |
| 86141 | 543 | 525 | $1K | |
| 71250 | 39 | 39 | $892.71 | |
| 90651 | 201 | 201 | $790.20 | |
| 81001 | 1,211 | 1,128 | $699.89 | |
| 83735 | 1,020 | 699 | $689.69 | |
| 80076 | 1,292 | 1,207 | $659.80 | |
| 36000 | 525 | 284 | $652.74 | |
| 83540 | 687 | 675 | $620.74 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 670 | 637 | $610.33 |
| 87088 | 667 | 634 | $559.43 | |
| 71045 | Radiologic examination, chest; single view | 461 | 419 | $404.05 |
| 97802 | 201 | 173 | $364.20 | |
| 83690 | 546 | 496 | $362.63 | |
| 84484 | 584 | 516 | $321.53 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3,081 | 2,976 | $314.10 |
| 82565 | 669 | 596 | $288.55 | |
| 87340 | 222 | 218 | $286.40 | |
| 85730 | 602 | 547 | $263.97 | |
| 83880 | 347 | 324 | $241.20 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 137 | 137 | $231.87 |
| 84100 | 657 | 447 | $197.83 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 346 | 316 | $178.77 |
| 85651 | 20 | 20 | $169.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 27 | 27 | $154.00 |
| 86580 | 59 | 57 | $124.50 | |
| 86900 | 143 | 109 | $123.84 | |
| 85652 | 490 | 475 | $116.76 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,272 | 840 | $98.44 |
| 87522 | Neg quan hep c or qual rna | 178 | 174 | $97.25 |
| 86901 | 141 | 108 | $94.55 | |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | 26 | 20 | $89.80 |
| 82610 | 26 | 26 | $88.14 | |
| 87430 | 28 | 28 | $75.71 | |
| 83605 | 214 | 192 | $58.57 | |
| 86803 | 253 | 250 | $56.52 | |
| 81002 | 365 | 358 | $56.01 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 405 | 338 | $54.70 |
| 90686 | 1,771 | 1,770 | $54.22 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 98 | 75 | $47.55 |
| 90723 | 397 | 389 | $45.00 | |
| 90680 | 344 | 339 | $45.00 | |
| 73630 | 30 | 28 | $43.59 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 41 | 12 | $43.16 |
| 84439 | 369 | 361 | $43.13 | |
| 87186 | 73 | 69 | $40.88 | |
| 29581 | 41 | 12 | $38.67 | |
| 87077 | 82 | 77 | $38.23 | |
| 36415 | Collection of venous blood by venipuncture | 554 | 478 | $38.00 |
| 87081 | 18 | 18 | $37.20 | |
| 90715 | 142 | 140 | $36.51 | |
| 83655 | 158 | 158 | $36.40 | |
| 90647 | 351 | 349 | $36.00 | |
| 92015 | Determination of refractive state | 81 | 81 | $35.24 |
| 85018 | 230 | 174 | $33.68 | |
| 0250 | 102 | 61 | $32.45 | |
| 81003 | 213 | 206 | $28.09 | |
| 85008 | 103 | 101 | $27.44 | |
| 86706 | 173 | 172 | $23.72 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 139 | 104 | $23.50 |
| 84450 | 199 | 166 | $21.87 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 13 | 13 | $17.92 |
| 82550 | 81 | 70 | $17.69 | |
| 85014 | 83 | 81 | $17.01 | |
| 84132 | 167 | 158 | $15.13 | |
| 81025 | 12 | 12 | $14.00 | |
| 86704 | 72 | 72 | $10.83 | |
| 82247 | 41 | 29 | $9.94 | |
| 84165 | 60 | 60 | $9.58 | |
| 70355 | 26 | 26 | $8.58 | |
| 94150 | 40 | 40 | $4.79 | |
| 90662 | 995 | 995 | $0.29 | |
| 90656 | 321 | 320 | $0.08 | |
| 82274 | 863 | 860 | $0.00 | |
| 92133 | 129 | 129 | $0.00 | |
| 90633 | 290 | 284 | $0.00 | |
| 94729 | 27 | 27 | $0.00 | |
| 84550 | 228 | 222 | $0.00 | |
| 90707 | 154 | 152 | $0.00 | |
| 90710 | 57 | 56 | $0.00 | |
| 99152 | 25 | 25 | $0.00 | |
| 90700 | 126 | 124 | $0.00 | |
| 99188 | 16 | 16 | $0.00 | |
| 94726 | 14 | 14 | $0.00 | |
| 86708 | 12 | 12 | $0.00 | |
| 90734 | 142 | 142 | $0.00 | |
| 92083 | 13 | 13 | $0.00 | |
| 85045 | 29 | 28 | $0.00 | |
| 84156 | 44 | 41 | $0.00 | |
| 97803 | 91 | 89 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 14 | 14 | $0.00 |
| 97164 | 12 | 12 | $0.00 | |
| 73030 | 13 | 13 | $0.00 | |
| 86480 | 32 | 32 | $0.00 | |
| 97116 | 33 | 24 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 80 | 62 | $0.00 |
| 82040 | 26 | 25 | $0.00 | |
| 94760 | 132 | 124 | $0.00 | |
| 90716 | 159 | 157 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 155 | 154 | $0.00 |
| 88142 | 27 | 27 | $0.00 | |
| 86361 | 120 | 117 | $0.00 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 42 | 41 | $0.00 |
| 90696 | 52 | 51 | $0.00 | |
| 90480 | 22 | 22 | $0.00 | |
| 94010 | 28 | 28 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 13 | 13 | $0.00 |
| 73564 | 28 | 27 | $0.00 | |
| 87205 | 30 | 27 | $0.00 | |
| 94200 | 13 | 13 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 13 | 13 | $0.00 |